KR102194314B1 - Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain - Google Patents
Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain Download PDFInfo
- Publication number
- KR102194314B1 KR102194314B1 KR1020200077079A KR20200077079A KR102194314B1 KR 102194314 B1 KR102194314 B1 KR 102194314B1 KR 1020200077079 A KR1020200077079 A KR 1020200077079A KR 20200077079 A KR20200077079 A KR 20200077079A KR 102194314 B1 KR102194314 B1 KR 102194314B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- green tea
- lactobacillus rhamnosus
- fermented
- extract
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- 239000000284 extract Substances 0.000 title claims abstract description 50
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 49
- 235000009569 green tea Nutrition 0.000 title claims abstract description 46
- 241000218588 Lactobacillus rhamnosus Species 0.000 title claims abstract description 44
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 23
- 239000002537 cosmetic Substances 0.000 title claims abstract description 19
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 17
- 244000005714 skin microbiome Species 0.000 title claims description 13
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 14
- 230000002087 whitening effect Effects 0.000 claims abstract description 14
- 241000894006 Bacteria Species 0.000 claims description 25
- 235000013305 food Nutrition 0.000 claims description 19
- 235000020688 green tea extract Nutrition 0.000 claims description 16
- 229940094952 green tea extract Drugs 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000009286 beneficial effect Effects 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000012423 maintenance Methods 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 6
- 230000003796 beauty Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 239000006041 probiotic Substances 0.000 abstract description 2
- 230000000529 probiotic effect Effects 0.000 abstract description 2
- 235000018291 probiotics Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 59
- 230000000694 effects Effects 0.000 description 23
- 238000000855 fermentation Methods 0.000 description 18
- 230000004151 fermentation Effects 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- 239000000523 sample Substances 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- 102000003425 Tyrosinase Human genes 0.000 description 11
- 108060008724 Tyrosinase Proteins 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 11
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 9
- -1 for example Substances 0.000 description 9
- 230000007760 free radical scavenging Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- 229920002674 hyaluronan Polymers 0.000 description 6
- 229960003160 hyaluronic acid Drugs 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000186427 Cutibacterium acnes Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229940055019 propionibacterium acne Drugs 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 241000194020 Streptococcus thermophilus Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000003570 cell viability assay Methods 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 229940049294 glyceryl stearate se Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012175 pyrosequencing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004321 EU approved sweetener Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000270347 Iguania Species 0.000 description 1
- 241000087799 Koma Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 239000006244 Medium Thermal Substances 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000566145 Otus Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000282335 Procyon Species 0.000 description 1
- 241000287530 Psittaciformes Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 244000005702 human microbiome Species 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A23Y2220/73—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
Description
본 발명은 락토바실러스 람노서스를 이용한 녹차 발효 추출물에 관한 것이다. 상기 녹차 발효 추출물은 항산화, 미백 및 보습 효과가 우수한 프로바이오틱스 조성물로, 피부 미용 증진을 위한 용도에 다양하게 활용될 수 있다.The present invention relates to a green tea fermented extract using Lactobacillus rhamnosus. The green tea fermented extract is a probiotic composition having excellent antioxidant, whitening, and moisturizing effects, and may be used in various applications for enhancing skin beauty.
피부는 신체의 외부를 덮고 있는 하나의 막으로 여러 가지 외부의 자극, 장해, 건조 등의 환경요소로부터 신체를 보호해 주는 다양한 생리적 기능을 수행하여 내부 장기와 그 밖의 체내 기관을 보호 조절하는 역할을 한다. The skin is a single membrane covering the outside of the body and plays a role in protecting and regulating internal organs and other internal organs by performing various physiological functions that protect the body from environmental factors such as various external stimuli, obstacles, and dryness. do.
그러나, 피부는 연령이 증가함에 따라 생체의 생리적 기능이 저하되어 신진 대사를 조절하는 각종 호르몬의 분비가 감소하고, 면역 세포의 기능과 세포들의 활성이 저하되게 된다. 또한 광 또는 열에 반복적인 노출로 인해 피부의 외양 또는 기능이 변하게 되는데, 이로 인해 자유라디칼 및 활성 유해 산소 등이 증가함으로써 과도한 물리적, 화학적 자극 및 스트레스 등은 피부의 정상 기능 저하, 멜라닌 침착에 의한 기미, 주근깨 등의 생성 및 피부 노화현상을 촉진하여 피부를 손상시키게 된다. However, as the skin ages, the physiological function of the living body decreases, the secretion of various hormones regulating metabolism decreases, and the function of immune cells and the activity of cells decrease. In addition, the appearance or function of the skin changes due to repeated exposure to light or heat. As a result, free radicals and free radicals and free radicals increase. Excessive physical and chemical irritation and stress are caused by deterioration of normal skin function and melanin deposition. It damages the skin by promoting the generation of freckles and skin aging.
이러한 피부노화 및 손상을 방지하여 보다 건강하고 아름다운 피부를 유지하기 위하여 각종 동물, 식물, 미생물 등으로부터 얻어진 생리 활성 물질들을 화장품에 부가하여 사용함으로써 피부의 고유 기능을 유지시키고 피부 세포를 활성화시켜 피부 신진대사를 촉진하여 피부 건강을 유지하고자 하는 노력이 계속되고 있으며, 이에 따른 화장품, 피부 외용제 등이 개발되고 있다.In order to prevent such skin aging and damage to maintain healthier and more beautiful skin, by adding physiologically active substances obtained from various animals, plants, microorganisms, etc. to cosmetics, it maintains the skin's own function and activates the skin cells to make the skin budding. Efforts to maintain skin health by promoting metabolism are continuing, and cosmetics and external preparations for skin are being developed accordingly.
그러나, 이들 물질은 피부 적용시 자극, 홍반, 발적 등의 안전성 문제로 사용량의 제한이 있거나, 효과가 미미하여 실질적으로 피부 기능 개선 효과를 기대기 어려웠다. 따라서, 기존의 피부 외용제 조성물 보다 생체에 안전하고 효과가 높은 새로운 피부 외용제 조성물의 개발이 요구되고 있다.However, when these substances are applied to the skin, the amount of use of these substances is limited due to safety problems such as irritation, erythema, and redness, or the effect is insignificant, making it difficult to substantially improve skin function. Therefore, there is a need to develop a new composition for external application for skin that is safer to the living body and has higher effect than the existing composition for external application for skin.
본 발명의 목적은 락토바실러스 람노서스(Lactobacillus rhamnosus) 균주를 접종하여 발효시킨 녹차 발효 추출물을 포함하는 항산화용 또는 피부 마이크로바이옴 균형 유지용 화장료 조성물을 제공하는 것이다.An object of the present invention is to provide a cosmetic composition for antioxidant or skin microbiome balance maintenance comprising a green tea fermented extract fermented by inoculating a strain of Lactobacillus rhamnosus .
본 발명의 다른 목적은 상기 락토바실러스 람노서스(Lactobacillus rhamnosus) 균주를 접종하여 발효시킨 녹차 발효 추출물을 포함하는 항산화용 또는 피부 마이크로바이옴 균형 유지용 식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a food composition for antioxidant or skin microbiome balance maintenance comprising a green tea fermented extract fermented by inoculating the Lactobacillus rhamnosus strain.
상기와 같은 목적을 달성하기 위한 본 발명의 일 측면은 락토바실러스 람노서스(Lactobacillus rhamnosus) 균주를 접종하여 발효시킨 녹차 발효 추출물을 포함하는 항산화용 또는 피부 마이크로바이옴 균형 유지용 화장료 조성물에 관한 것이다.One aspect of the present invention for achieving the above object relates to a cosmetic composition for antioxidant or skin microbiome balance maintenance comprising a green tea fermented extract fermented by inoculating a strain of Lactobacillus rhamnosus .
본 발명에서, “녹차(Camellia Sinensis)”는 차나무과에 속하는 상록활엽관목으로, 이 잎을 건조한 차는 다방면에 활용되고 있다. 특히 항산화 작용, 항암작용, 심혈관계에 있어 혈중 지질 감소 작용, 혈액 순환 촉진 작용을 나타내는 것으로 알려져 있다.In the present invention, “green tea ( Camellia Sinensis )” is an evergreen broad-leaved shrub belonging to the tea tree family, and tea with dried leaves is used in many ways. In particular, it is known to exhibit antioxidant, anti-cancer, cardiovascular, blood lipid-reducing, and blood circulation-stimulating effects.
본 발명의 “추출물”은 녹차의 추출 처리에 의하여 얻어지는 추출액, 상기 추출액들의 희석액이나 농축액, 상기 추출액을 건조하여 얻어지는 건조물, 상기 추출액의 조제물이나 정제물, 또는 이들의 혼합물 등, 추출액 자체 및 추출액을 이용하여 형성 가능한 모든 제형의 추출물을 포함한다. The "extract" of the present invention refers to an extract obtained by extracting green tea, a dilution or concentrate of the extracts, a dried product obtained by drying the extract, a preparation or purified product of the extract, or a mixture thereof, the extract itself and the extract It includes extracts of all formulations that can be formed using.
상기 추출물은, 상기 녹차의 천연, 잡종 또는 변종 식물로부터 추출될 수 있고, 식물 조직 배양물로부터도 추출이 가능하다.The extract may be extracted from natural, hybrid or variant plants of the green tea, and may also be extracted from plant tissue culture.
상기 녹차 추출물의 추출용매 종류는 특별히 제한되지 아니하며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 추출 용매의 비제한적인 예로는 물, 알코올, 에틸아세테이트, 아세톤, 핵산, 디클로로메탄 또는 이들의 혼합 용매를 사용할 수 있다.The type of the extraction solvent of the green tea extract is not particularly limited, and any solvent known in the art may be used. As a non-limiting example of the extraction solvent, water, alcohol, ethyl acetate, acetone, nucleic acid, dichloromethane, or a mixed solvent thereof may be used.
본 발명에서 “발효”는 발효 균주 자신이 가지고 있는 효소를 이용해 유기물을 분해시키는 과정을 의미한다. 발효 균주를 통한 발효과정을 거친 원료는 발효 전보다 최소 2배에서 최대 수십배의 효과가 증대되는 것으로 알려져 있다. 특히 발효를 거친 대사물질은 피부에 좋은 각종 아미노산, 유기산, 항산화물질을 함유하여 피부대사를 촉진시켜 피부결을 매끄럽게 가꿔줄 수 있으며, 발효과정을 거치면서 입자가 작아지고 중금속 등의 독성이 분해되어 피부트러블이나 알레르기 부작용을 완화시켜줄 수 있다고 알려져 있다.In the present invention, "fermentation" refers to a process of decomposing organic matter using enzymes possessed by the fermentation strain itself. It is known that raw materials that have undergone a fermentation process through a fermentation strain have an effect of at least two to tens of times greater than before fermentation. In particular, metabolites that have undergone fermentation contain various amino acids, organic acids, and antioxidants that are good for the skin, and can promote skin metabolism to smooth the skin texture, and through the fermentation process, particles become smaller and toxicities such as heavy metals are decomposed. It is known that it can relieve skin problems or allergic side effects.
구체적으로, 상기 발효 균주는 락토바실러스 람노서스일 수 있으며, 보다 구체적으로 상기 락토바실러스 람노서스는 락토바실러스 람노서스 AMI-1301(Lactobacillus rhamnosus AMI-1301) KCCM12741P일 수 있다.Specifically, the fermentation strain may be Lactobacillus rhamnosus , and more specifically, the Lactobacillus rhamnosus may be Lactobacillus rhamnosus AMI-1301 ( Lactobacillus rhamnosus AMI-1301) KCCM12741P.
상기 “락토바실러스 람노서스 AMI-1301(Lactobacillus rhamnosus AMI-1301)”는 유아의 피부에서 분리 및 동정된 락토바실러스 람노서스의 신규한 유산균으로, 한국미생물보존센터에 2020년 6월 3일자로 기탁하였다(수탁번호 KCCM12741P).The “ Lactobacillus rhamnosus AMI-1301” is a novel lactic acid bacteria of Lactobacillus rhamnosus isolated and identified from the skin of infants, and was deposited with the Korea Microbiology Conservation Center on June 3, 2020. (Accession No. KCCM12741P).
본 발명에서, “항산화”란, 산화를 억제하는 작용을 의미하는 것으로, 인체는 산화촉진물질과 산화억제물질이 균형을 이루고 있으나, 여러 가지 요인들로 인하여 이러한 균형 상태를 잃고 산화를 촉진하는 방향으로 기울게 되면, 생체 내에 산화적 스트레스(oxidative stress)가 유발되어 세포손상 및 병리적 질환을 유발하게 된다. 이러한 산화적 스트레스의 직접적 원인이 되는 활성 산소종(reactive oxygen species, ROS)은 화학적으로 불안정하고 반응성이 높아 DNA, 단백질, 지질 및 탄수화물과 같은 여러 생체물질과 쉽게 반응할 수 있으며, 생체 내 고분자들을 공격하여 세포와 조직에 비가역적인 손상을 일으키거나 돌연변이, 세포독성 및 암 등을 초래하게 되고, 노화의 직접적인 원인이 되기도 한다. 이러한 활성 산소종을 제거하거나 감소시킴으로써 항산화 효과를 얻어 노화를 방지하고 건강을 유지할 수 있게 된다.In the present invention, “antioxidation” refers to an action of inhibiting oxidation, and in the human body, an oxidation promoting substance and an oxidation inhibitor are in balance, but due to various factors, the balance is lost and the direction of promoting oxidation When inclined toward, oxidative stress is induced in a living body, leading to cell damage and pathological diseases. Reactive oxygen species (ROS), which are the direct cause of oxidative stress, are chemically unstable and highly reactive, so they can easily react with various biomaterials such as DNA, proteins, lipids, and carbohydrates. Attacks cause irreversible damage to cells and tissues, or cause mutations, cytotoxicity and cancer, and are also a direct cause of aging. By removing or reducing these reactive oxygen species, antioxidant effects are obtained, preventing aging and maintaining health.
본 발명에서 “마이크로바이옴(microbiome)”은 미생물군집(microbiota) 및 유전체(genome)의 합성어로서 인간, 동식물, 토양, 바다, 호수, 암벽, 대기 등에 공존하는 미생물 군집과 유전체 전체를 의미한다. 그 중에서 피부 내 마이크로바이옴은 피부 내에 존재하는 미생물과 미생물, 숙주와 미생물 간의 복잡한 상호관계를 이루는 미생물군으로서, 인간 마이크로바이옴의 일부를 일컫는다.In the present invention, “microbiome” is a compound word of microbiota and genome, and refers to a microbial community and the entire genome that coexist in humans, animals and plants, soil, sea, lake, rock wall, atmosphere, and the like. Among them, the microbiome in the skin is a microbial group that forms a complex interrelationship between microbes and microbes, and hosts and microbes existing in the skin, and refers to a part of the human microbiome.
상기 “피부 마이크로바이옴 균형 유지”는 피부 내 유익균을 증식시키거나, 피부 내 유해균의 증식을 억제함으로써 피부 내 미생물군집의 균형을 증진시키고, 피부 환경을 개선시키는 것을 의미한다.The "maintaining the skin microbiome balance" means to increase the balance of microbial communities in the skin and improve the skin environment by proliferating beneficial bacteria in the skin or inhibiting the proliferation of harmful bacteria in the skin.
본 발명에서는 녹차 추출물을 신규 균주인 락토바실러스 람노서스 AMI-1301 균주로 발효시킬 경우, 기존 공지된 락토바실러스 람노서스 균주를 이용한 녹차 발효 추출물에 비해 항산화 효과가 현저하게 증가하고, 피부 마이크로바이옴 균형 유지에 효과적임을 확인하였는 바, 락토바실러스 람노서스 AMI-1301 균주로 발효시킨 항산화 용도의 녹차 발효 추출물을 제공하고자 한다.In the present invention, when the green tea extract is fermented with the new strain Lactobacillus rhamnosus AMI-1301 strain, the antioxidant effect is remarkably increased compared to the green tea fermented extract using the existing known Lactobacillus rhamnosus strain, and skin microbiome balance As it has been confirmed that it is effective in maintenance, we intend to provide a green tea fermented extract for antioxidant use fermented with Lactobacillus rhamnosus AMI-1301 strain.
구체적으로 상기 마이크로바이옴 균형 유지는 피부 유익균을 증진시키거나 또는 피부 유해균을 억제시키는 것일 수 있다. Specifically, maintaining the balance of the microbiome may promote skin beneficial bacteria or inhibit skin harmful bacteria.
본 발명에서 “피부 유익균 증진”이란, 피부 속에는 2 cm2당 약 1000가지 종류의 200만개 이상의 미생물이 존재하는데 이 중 피부 내 유익균의 생육 및 활성을 증진시킴으로써 피부 내 미생물 균형을 유지하는 것을 의미한다. In the present invention, "promoting skin beneficial bacteria" means that there are about 1,000 kinds of 2 million or more microorganisms per 2 cm 2 in the skin, of which, by enhancing the growth and activity of beneficial bacteria in the skin, it means maintaining the balance of microorganisms in the skin. .
본 발명에서 “피부 유해균 억제”란, 피부 내 유해균의 증식을 억제하거나 유해균을 불활성화 시킴으로써 피부 내 미생물 균형을 유지하는 것을 의미한다.In the present invention, "inhibition of harmful bacteria" means maintaining the balance of microorganisms in the skin by inhibiting the proliferation of harmful bacteria in the skin or inactivating harmful bacteria.
본 발명의 일 실시예에서 상기 녹차 추출물에 락토바실러스 람노서스 AMI-1301 균주로 접종하고 자유라디칼(free radical) 소거활성을 측정하여 항산화 효과를 확인한 결과, 상기 발효 추출물이 기존 공시 균주인 락토바실러스 람노서스로 발효시킨 녹차 발효 추출물에 비해 항산화 효과가 현저히 상승되는 것을 확인하였다(도 1 및 도 2).In one embodiment of the present invention, as a result of inoculating the green tea extract with Lactobacillus rhamnosus AMI-1301 strain and measuring the free radical scavenging activity to confirm the antioxidant effect, the fermentation extract is Lactobacillus rhamno It was confirmed that the antioxidant effect was remarkably increased compared to the green tea fermented extract fermented with sususe (FIGS. 1 and 2 ).
본 발명의 일 실시예에서는 상기 화장료 조성물이 피부 유익균의 증식을 촉진시키면서 유해균의 증식을 억제하여, 피부 속 마이크로바이옴 균형이 증진될 수 있음을 확인하였다(표 4 및 표 6). In one embodiment of the present invention, it was confirmed that the cosmetic composition promotes the proliferation of beneficial skin bacteria while inhibiting the proliferation of harmful bacteria, thereby enhancing the microbiome balance in the skin (Tables 4 and 6).
상기 조성물은 피부 미백 또는 피부 보습 용도를 추가로 더 포함할 수 있다.The composition may further include skin whitening or skin moisturizing use.
본 발명에서 “미백”이란, 피부의 톤을 밝게 하는 것으로, 멜라닌의 과도한 합성이나, 티로시네이즈 효소의 활성, 멜라닌의 생성 등으로 인한 기미, 주근깨 등의 다양한 색소 침착을 완화 또는 개선시키는 것이다. 상기 미백효과를 통해 피부톤 또는 안색이 개선될 수 있다.In the present invention, "whitening" is to brighten the tone of the skin, and to alleviate or improve various pigmentation such as spots and freckles caused by excessive synthesis of melanin, activity of tyrosinase enzyme, and production of melanin. Skin tone or complexion may be improved through the whitening effect.
본 발명에서 “피부 보습”이란 피부에 수분을 공급하여 보충하거나, 피부의 수분이 빠져나가지 않도록 보호하는 것을 모두 포함한다. 일반적으로 피부의 수분량은 진피층에서는 약 70% 정도이나 표피층으로 갈수록 감소하여 각질층에서는 약 10 내지 30%가 된다. 이러한 세포 층의 수분함량이 10% 이하로 되면 피부가 거칠어지고 신체 보호 기능이 약화되어 노화 현상이 나타나게 되는 바, 수분 공급 및 보습은 피부 보호에 중요하다. In the present invention, the term “skin moisturizing” includes both supplementing by supplying moisture to the skin or protecting the skin from escaping moisture. In general, the amount of moisture in the skin is about 70% in the dermis layer, but decreases toward the epidermis layer to become about 10 to 30% in the stratum corneum. When the moisture content of such a cell layer is less than 10%, the skin becomes rough and the body protective function is weakened, resulting in aging, and moisture supply and moisturization are important for skin protection.
본 발명의 일 실시예에서는 락토바실러스 람노서스 AMI-1301 균주를 이용하여 수득한 녹차 발효 추출물을 처리하는 경우, 티로시네이즈 활성 억제 효과가 현저히 증가하였는 바(도 3), 미백 용도, 전체적인 피부 안색 및 피부톤 개선 용도로 활용될 수 있음을 확인하였다.In one embodiment of the present invention, when the green tea ferment extract obtained using the Lactobacillus rhamnosus AMI-1301 strain was treated, the inhibitory effect of tyrosinase activity was significantly increased (FIG. 3 ), whitening use, overall skin complexion And it was confirmed that it can be used for improving skin tone.
본 발명의 일 실시예에서는 피부 보습인자인 히알루론산(Hyaluronic Acid)의 생성량을 측정한 결과, 락토바실러스 람노서스 AMI-1301로 발효시킨 녹차 발효 추출물에서 현저히 가하는 효과가 나타났는 바, 피부 수분 함량 증가를 통한 피부 보습에 뛰어난 효과가 있음을 확인하였다(표 3).In one embodiment of the present invention, as a result of measuring the amount of production of hyaluronic acid, which is a skin moisturizing factor, a significant effect was found in the green tea fermented extract fermented with Lactobacillus rhamnosus AMI-1301, and the skin moisture content increased. It was confirmed that there is an excellent effect on skin moisturizing through (Table 3).
상기 녹차 발효 추출물은 조성물 총 중량에 대해 0.001 내지 30 중량%로 포함될 수 있으며, 상기 범위 내에서 우수한 항산화, 미백 및 보습 효과가 나타나는 이점이 있으며, 조성물의 제형이 안정화되는 이점이 있다.The green tea fermented extract may be included in an amount of 0.001 to 30% by weight based on the total weight of the composition, and has the advantage of exhibiting excellent antioxidant, whitening, and moisturizing effects within the above range, and the formulation of the composition is stabilized.
본 발명의 화장료 조성물은 용액, 외용 연고, 크림, 수딩젤, 폼, 영양 화장수, 유연 화장수, 팩, 유연수, 바디워시, 유액, 메이크업 베이스, 에센스, 비누, 액체 세정료, 입욕제, 선 스크린 크림, 선 오일, 현탁액, 유탁액, 페이스트, 겔, 로션, 파우더, 비누, 폼 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 패취 및 스프레이로 구성된 군으로부터 선택되는 제형으로 제조할 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention is a solution, external ointment, cream, soothing gel, foam, nutrient lotion, flexible lotion, pack, softening water, body wash, emulsion, makeup base, essence, soap, liquid detergent, bath agent, sunscreen cream, sun Oil, suspension, emulsion, paste, gel, lotion, powder, soap, foam cleansing, oil, powder foundation, emulsion foundation, wax foundation, can be prepared in a formulation selected from the group consisting of a patch and spray, but limited thereto. It does not become.
본 발명의 상기 화장료 조성물은 일반 피부 화장료에 배합되는 화장품학적으로 허용 가능한 담체를 1 종 이상 추가로 포함할 수 있으며, 통상의 성분으로 예를 들면 유분, 물, 계면 활성제, 보습제, 저급 알코올, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may additionally include one or more cosmetically acceptable carriers blended in general skin cosmetics, and as common ingredients, for example, oil, water, surfactants, moisturizers, lower alcohols, thickeners , A chelating agent, a colorant, a preservative, a fragrance, and the like may be appropriately blended, but are not limited thereto.
본 발명의 화장료 조성물에 포함되는 화장품학적으로 허용 가능한 담체는 화장료 조성물의 제형에 따라 다양하다.The cosmetically acceptable carrier included in the cosmetic composition of the present invention varies depending on the formulation of the cosmetic composition.
본 발명의 제형이 연고, 페이스트, 크림 또는 젤인 경우에는, 담체 성분으로서 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화 아연 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is an ointment, paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide, etc. May be used, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 파우더 또는 스프레이인 경우에는, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더 등이 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로하드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진제를 포함할 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, etc. may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohard It may include a propellant such as locarbon, propane/butane or dimethyl ether, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 용액 또는 유탁액인 경우에는, 담체 성분으로서 용매, 용해화제 또는 유탁화제 등이 이용될 수 있으며, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일 등이 이용될 수 있고, 특히, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일 및 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Propylene glycol, 1,3-butyl glycol oil, and the like may be used, and in particular, cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan May be used, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 현탁액인 경우에는, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타하이드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2 종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, micro Crystalline cellulose, aluminum metahydroxide, bentonite, agar, or tracant may be used, but are not limited thereto. These may be used alone or in combination of two or more.
본 발명의 조성물은 피부에 직접 도포하거나 살포하는 등의 경피 투여 방법으로 사용될 수 있으며, 본 발명 조성물의 투여 경로는 목적조직에 도달할 수 있는 한 어떠한 일반적인 경로를 통하여 투여될 수 있다. The composition of the present invention may be used as a transdermal administration method such as direct application or spraying on the skin, and the administration route of the composition of the present invention may be administered through any general route as long as it can reach the target tissue.
본 발명의 조성물의 사용량은 연령, 병변의 정도 등의 개인 차이나 제형에 따라 적절하게 조절될 수 있으며, 1일 1회 내지 수회 적?韜?을 피부에 도포하여 1 주일 내지 수개월 사용될 수 있다.The amount of use of the composition of the present invention may be appropriately adjusted according to individual differences or formulations such as age and degree of lesions, and may be used from one week to several months by applying one or several times a day to the skin.
본 발명의 다른 측면은 락토바실러스 람노서스 균주를 접종하여 발효시킨 녹차 발효 추출물을 포함하는 항산화용 또는 피부 마이크로바이옴 균형 유지용 식품 조성물에 관한 것이다.Another aspect of the present invention relates to a food composition for antioxidant or skin microbiome balance maintenance comprising a green tea fermented extract fermented by inoculating Lactobacillus rhamnosus strain.
구체적으로, 상기 락토바실러스 람노서스는 락토바실러스 람노서스 AMI-1301(Lactobacillus rhamnosus AMI-1301) KCCM12741P일 수 있다.Specifically, the Lactobacillus rhamnosus may be Lactobacillus rhamnosus AMI-1301 ( Lactobacillus rhamnosus AMI-1301) KCCM12741P.
상기 “녹차 발효 추출물”, “락토바실러스 람노서스 AMI-1301”에 관한 설명은 전술한 바와 동일하다.The description of the “green tea ferment extract” and “Lactobacillus rhamnosus AMI-1301” is the same as described above.
상기 식품 조성물은 사람, 반려동물을 모두 포함하며, 예컨대 반려동물은 강아지, 고양이, 햄스터, 토끼, 닭, 이구아나, 기니피그, 저빌, 달팽이, 라쿤, 앵무새, 도마뱀, 열대어를 포함한 어류 등 인간과 더불어 살아가는 동물은 종류 불문하고 모두 포함한다.The food composition includes both humans and companion animals.For example, companion animals live with humans such as dogs, cats, hamsters, rabbits, chickens, iguanas, guinea pigs, gerbils, snails, raccoons, parrots, lizards, and fish including tropical fish. Animals of any kind are included.
본 발명의 녹차 발효 추출물을 첨가할 수 있는 식품은 육류, 빵, 소시지, 초콜릿류, 스넥류, 캔디류, 과자류, 라면, 피자, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 비타민 복합제, 건강기능성 보조식품 등이 있다. Foods to which the green tea ferment extract of the present invention can be added include meat, bread, sausage, chocolate, snacks, candy, confectionery, ramen, pizza, other noodles, gums, dairy products including ice cream, various soups, beverages, tea , Vitamin complexes, and health functional supplements.
상기 식품의 종류는 구체적으로 건강기능식품일 수 있다. 상기 건강기능 식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 유기산, 보호성 콜로이드 점증제, pH 조절제, 안정화제, 보존제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 이러한 성분은 단독으로 또는 조합으로 사용될 수 있으며, 이러한 첨가제의 비율은 조성물 전체 중량당 0.001 내지 50 중량부의 범위에서 선택되는 것이 일반적이다.The type of food may specifically be a health functional food. The health functional foods include various nutrients, vitamins, minerals (electrolytes), synthetic flavors and flavoring agents such as natural flavors, colorants and enhancers (cheese, chocolate, etc.), pectic acid and its salts, organic acids, protective colloidal growth It may contain an agent, a pH adjuster, a stabilizer, a preservative, glycerin, alcohol, a carbonation agent used in carbonated beverages, and the like. These components may be used alone or in combination, and the proportion of these additives is generally selected from 0.001 to 50 parts by weight per total weight of the composition.
상기 건강기능식품은 식품의 생체 조절 기능을 강조한 식품으로 물리적, 생화학적, 생물공학적인 방법을 이용하여 특정 목적에 작용 및 발현하도록 부가가치를 부여한 식품이다. 이러한 건강기능 식품의 성분은 생체 방어와 신체 리듬의 조절, 질환의 방지 및 회복에 관계하는 신체 조절 기능을 생체에 대하여 충분히 발휘하도록 설계하여 가공하게 되며, 식품으로 허용 가능한 식품 보조 첨가제, 감미료 또는 기능성 원료를 함유할 수 있다. The health functional food is a food that emphasizes the biological regulation function of food, and is a food that has added value to act and express it for a specific purpose by using physical, biochemical, and bioengineering methods. Ingredients of these health functional foods are designed and processed to fully exert the body's control functions related to body defense, regulation of body rhythm, prevention and recovery of diseases to the living body, and food additives, sweeteners, or functional foods acceptable as foods. It may contain raw materials.
상기 건강기능식품은 정제, 과립, 분말, 캅셀, 액상의 용액 및 환으로 이루어진 군에서 선택된 어느 하나의 제형일 수 있으나, 이에 제한되지 않는다. The health functional food may be any one formulation selected from the group consisting of tablets, granules, powders, capsules, liquid solutions, and pills, but is not limited thereto.
또한, 상기 식품의 종류는 식품 첨가제일 수 있으며, 상기 식품 첨가제는 식품의 제조, 가공, 또는 보존을 위해 식품에 첨가, 혼합, 침윤 기타의 방법에 의해 사용되는 물질을 의미한다. 상기 식품 첨가제는 천연물과 합성품이 있으며, 기능과 용도에 따라 분류할 수 있다. 현재 한국에 식품첨가물로 허가되어 있는 품목은 화학적 합성품 370여종, 천연첨가물 50여종이며, 주로 용도에 따라 보존료, 살균제, 산화방지제, 착색료, 발색제, 표백제, 조미료, 감미료, 착향료, 팽창제, 강화제, 개량제, 유화제, 증점제(호료) 및 안정제, 피막제, 껌 기초제, 소포제, 용제, 이형제, 방충제, 품질개량제와 기타 식품제조용 첨가제 등으로 분류되어 쓰이고 있다.In addition, the type of food may be a food additive, and the food additive refers to a substance used by a method such as adding, mixing, infiltrating or adding to food for manufacturing, processing, or preserving food. The food additives include natural products and synthetic products, and can be classified according to functions and uses. Currently, 370 kinds of chemical synthetic products and 50 kinds of natural additives are approved as food additives in Korea. Depending on the purpose, preservatives, fungicides, antioxidants, coloring agents, coloring agents, bleaching agents, seasonings, sweeteners, flavoring agents, expanding agents, strengthening agents, and improving agents , Emulsifiers, thickeners and stabilizers, coating agents, gum base agents, defoaming agents, solvents, releasing agents, insect repellents, quality improvers and other additives for food manufacturing.
상기 식품첨가제의 형태는 분말, 과립, 정제, 캡슐 또는 액상 형태를 포함할 수 있으며 구체적으로는 캡슐의 형태일 수 있으나, 상기 형태에 제한되는 것은 아니다.The form of the food additive may include a powder, granule, tablet, capsule or liquid form, and specifically may be a capsule form, but is not limited to the form.
본 발명의 녹차 발효 추출물을 식품용 조성물로 사용할 경우, 상기 녹차 발효 추출물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용하고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 상기 녹차 발효 추출물의 혼합량은 그의 사용 목적(예방, 건강 또는 개선, 치료적 처치)에 따라 적합하게 결정될 수 있다. 나아가, 피부 미용 증진 용도로서 각종 생활용품, 반려용품 등에 제한되지 않고 적용될 수 있다.When the green tea fermented extract of the present invention is used as a food composition, the green tea fermented extract may be added as it is or used with other foods or food ingredients, and may be appropriately used according to a conventional method. The mixing amount of the green tea fermented extract may be appropriately determined according to the purpose of use (prevention, health or improvement, therapeutic treatment). Further, it can be applied without limitation to various household products, companion products, etc. as a use for enhancing skin beauty.
본 발명의 락토바실러스 람노서스를 이용한 녹차 발효 추출물은 항산화 활성을 통한 피부 노화 방지에 우수한 효과가 있을 뿐 아니라, 피부 미백 및 보습 효과를 가진다. 따라서, 이를 유효성분으로 포함하는 본 발명의 조성물은 피부 노화방지, 미백 및 보습을 통하여 우수한 피부 미용 증진 효과를 나타낼 수 있기 때문에, 화장품, 기능성 식품의 소재로서 유용하게 활용될 수 있다. The green tea fermented extract using Lactobacillus rhamnosus of the present invention not only has an excellent effect in preventing skin aging through antioxidant activity, but also has skin whitening and moisturizing effects. Therefore, the composition of the present invention including this as an active ingredient can exhibit excellent skin beauty enhancement effects through skin aging prevention, whitening and moisturizing, and thus can be usefully used as a material for cosmetics and functional foods.
본 발명의 효과는 상기한 효과로 한정되는 것은 아니며, 본 발명의 상세한 설명 또는 청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야한다.The effects of the present invention are not limited to the above effects, and should be understood to include all effects that can be deduced from the configuration of the invention described in the detailed description or claims of the present invention.
도 1은 녹차 발효 추출물의 DPPH(2,2-Diphenyl 1-picrylhydrazyl radical) 자유라디칼 소거능을 측정한 결과를 나타낸 것이다.
도 2는 녹차 발효 추출물의 ABTS+[2,2'-Azino-bis(3-ethyl benzothiazoline-6-sulfonic acid)] 자유라디칼 소거능을 측정한 결과를 나타낸 것이다.
도 3은 녹차 발효 추출물의 티로시네이즈 억제 활성(Tyrosinase inhibition assay)을 측정한 결과를 나타낸 것이다.Figure 1 shows the results of measuring the DPPH (2,2-Diphenyl 1-picrylhydrazyl radical) free radical scavenging ability of the green tea fermented extract.
Figure 2 shows the results of measuring the ABTS + [2,2'-Azino-bis (3-ethyl benzothiazoline-6-sulfonic acid)] free radical scavenging ability of green tea fermented extract.
Figure 3 shows the results of measuring the tyrosinase inhibition activity (Tyrosinase inhibition assay) of the green tea fermented extract.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are only illustrative of the present invention, and the present invention is not limited by the following examples.
실시예 1. 녹차 발효 추출물의 제조Example 1. Preparation of fermented green tea extract
정제수로 세척하고 건조시킨 녹차 전초를 조분쇄하여 20 배의 추출용매(정제수)로 121℃ 15분간 고압 열수추출 하였다. The green tea outpost washed with purified water and dried was coarsely pulverized and extracted with hot water at 121°C for 15 minutes with 20 times the extraction solvent (purified water).
발효를 위한 종균은 멸균된 유산균 배양배지(Lactobacillus MRS Broth, 디프코, 미합중국)에서 배양된 락토바실러스 람노서스(Lactobacillus rhamnosus)를 사용하였으며, 배양이 완료된 후 1x109 cfu/ml 농도로 녹차 추출물에 접종하였다. 이때, 발효 균주는 유아 피부에서 직접 분리한 락토바실러스 람노서스 AMI-1301(Lactobacillus rhamnosus AMI-1301) KCCM12741P 를 이용하였다.Inoculum for the fermentation is inoculated with the Lactobacillus ramno suspension of green tea extract to 1x10 9 cfu / ml concentration after a was used, the incubation is complete (Lactobacillus rhamnosus) cultured in a sterilized lactic acid bacteria culture medium (Lactobacillus MRS Broth, deep nose, the United States of America) I did. At this time, the fermentation strain was used as Lactobacillus rhamnosus AMI-1301 ( Lactobacillus rhamnosus AMI-1301) KCCM12741P isolated directly from infant skin.
발효는 발효조를 이용하여 1~3일간, 25~35°C로 유지하며 진행하였다. 발효가 완료된 녹차 발효물은 원심분리하여 균체를 제거하고 0.2 μm 여과지를 이용하여 최종 여과하였다. 추출 여과된 녹차 추출물은 동결건조하여 사용하였다.Fermentation was carried out while maintaining at 25 to 35 °C for 1 to 3 days using a fermentation tank. The green tea fermentation product after the fermentation was completed was centrifuged to remove the cells, and finally filtered using 0.2 μm filter paper. The extracted filtered green tea extract was lyophilized and used.
비교예 1. 녹차 추출물의 제조Comparative Example 1. Preparation of green tea extract
정제수로 세척하고 건조시킨 녹차 전초를 조분쇄하여 20 배의 추출용매(정제수)로 121℃ 15분간 고압 열수추출 하였다. The green tea outpost washed with purified water and dried was coarsely pulverized and extracted with hot water at 121°C for 15 minutes with 20 times the extraction solvent (purified water).
비교예 2. 녹차 발효 추출물(락토바실러스 람노서스 공시 균주 이용)의 제조Comparative Example 2. Preparation of fermented green tea extract (using the disclosed strain of Lactobacillus rhamnosus)
상기 실시예 1과 녹차 발효 추출물의 제조방법은 동일하다. 다만, 락토바실러스 람노서스를 한국 미생물 보존센터에서 분양받은 락토바실러스 람노서스(Lactobacillus rhamnosus) KCCM 32405를 이용하여 발효하였다.The manufacturing method of the fermented green tea extract as in Example 1 is the same. However, Lactobacillus rhamnosus was fermented using Lactobacillus rhamnosus KCCM 32405, which was sold in Korea Microbial Conservation Center.
실시예 및 비교예는 하기 표 1에 나타내었다.Examples and comparative examples are shown in Table 1 below.
실험예 1. 녹차 발효 추출물의 항산화 효능 확인Experimental Example 1. Confirmation of antioxidant efficacy of green tea fermented extract
1-1. DPPH 자유라디칼 소거 활성 평가1-1. DPPH free radical scavenging activity evaluation
본 발명의 녹차 발효 추출물의 항산화 효능을 확인하기 위하여, 상기 실시예 1 및 비교예 1, 2 녹차 발효 추출물의 자유라디칼 소거 활성(free radical scavenging activity)을 평가하였다.In order to confirm the antioxidant efficacy of the green tea fermented extract of the present invention, the free radical scavenging activity of the green tea fermented extracts of Example 1 and Comparative Examples 1 and 2 was evaluated.
DPPH 측정법은 억제제(inhibitor)가 안정한 라디칼 DPPH(2,2-Diphenyl 1-picrylhydrazyl radical)를 소거하여 탈색되는 정도를 515 nm에서 흡광도를 측정하는 방법이다. 구체적으로, DPPH 용액 100 μL 에 상기 녹차 발효 추출물 100 μL 를 첨가한 뒤 빛을 외부로부터 차단하여 20 분간 상온에서 반응시킨 다음 515 nm에서 흡광도를 측정하여 대조군에 대한 흡광도의 감소 비율로서 항산화 활성도를 나타내었다. 상기 대조군은 비타민C를 이용하였고, 라디칼 DPPH의 50% 소거하는 농도(SC50)를 측정하고, 이를 대조군과 비교하였다.The DPPH measurement method is a method of measuring the absorbance at 515 nm to determine the degree of decolorization by scavenging the stable radical DPPH (2,2-Diphenyl 1-picrylhydrazyl radical) by an inhibitor. Specifically, after adding 100 μL of the green tea fermentation extract to 100 μL of DPPH solution, blocking the light from the outside, reacting at room temperature for 20 minutes, and then measuring the absorbance at 515 nm to show the antioxidant activity as a reduction ratio of the absorbance to the control group. Done. Vitamin C was used as the control group, and the concentration (SC 50 ) for scavenging 50% of the radical DPPH was measured, and this was compared with the control group.
[식 1][Equation 1]
DPPH 소거활성(%) = [1 - (실시예 또는 비교예 시료처리군의 흡광도/ 시료 무처리군의 흡광도)] X 100DPPH scavenging activity (%) = [1-(absorbance of the sample treatment group in the Example or Comparative Example / absorbance of the sample untreated group)]
그 결과, 도 1에 나타난 바와 같이 락토바실러스 람노서스 AMI-1301의 균주로 발효시킨 녹차 발효 추출물의 자유라디칼 소거능이 농도 의존적으로 증가함을 확인하였다. As a result, as shown in FIG. 1, it was confirmed that the free radical scavenging ability of the green tea fermented extract fermented with the strain of Lactobacillus rhamnosus AMI-1301 increased in a concentration-dependent manner.
1-2. ABTS 자유라디칼 소거 활성 평가1-2. ABTS free radical scavenging activity evaluation
실시예 1 및 비교예 1, 2의 녹차 발효 추출물의 자유라디칼 소거 활성(free radical scavenging activity)을 평가하였다.The free radical scavenging activity of the fermented green tea extracts of Example 1 and Comparative Examples 1 and 2 was evaluated.
ABTS 측정법은 항산화제가 청녹색의 라디칼 ABTS+[2,2'-아지노-비즈(3-에틸 벤조티아졸린-6-술폰산](ABTS+[2,2'-Azino-bis(3-ethyl benzothiazoline-6-sulfonic acid)])을 소거하여 무색의 ABTS로 전환되는 정도를 700 nm에서 측정하는 방법이다. 구체적으로, 7 mM ABTS 용액에 과황산칼륨(potassium persulfate)이 2.45 mM이 되도록 혼합한 후 암소에서 약 24시간 반응시키고 ABTS+ 용액을 시료와 혼합하여 암소에서 20분간 반응시켜 700 nm에서 흡광도를 측정하였다. 상기 대조군은 비타민C를 이용하였고, 라디칼 ABTS의 50% 소거하는 농도(SC50)를 측정하고, 이를 대조군과 비교하였다.In the ABTS measurement method, the antioxidant is blue-green radical ABTS + [2,2'-azino-beads (3-ethyl benzothiazoline-6-sulfonic acid] (ABTS + [2,2'-Azino-bis(3-ethyl benzothiazoline-6)). -sulfonic acid)]) is removed to measure the degree of conversion to colorless ABTS at 700 nm Specifically, in a dark place after mixing potassium persulfate to 2.45 mM in 7 mM ABTS solution After reacting for about 24 hours, the ABTS + solution was mixed with the sample and reacted in the dark for 20 minutes to measure the absorbance at 700 nm The control group used vitamin C, and the concentration (SC 50 ) to eliminate 50% of the radical ABTS was measured. And it was compared with the control.
그 결과, 도 2에 나타난 바와 같이 락토바실러스 람노서스 AMI-1301의 균주로 발효시킨 녹차 발효 추출물의 자유라디칼 소거능이 농도 의존적으로 증가함을 확인하였다.As a result, it was confirmed that the free radical scavenging ability of the green tea fermented extract fermented with the strain of Lactobacillus rhamnosus AMI-1301 increased in a concentration-dependent manner as shown in FIG. 2.
상기와 같은 결과는 본 발명의 녹차 발효 추출물이 녹차 추출물 또는 기존 공지된 락토바실러스 람노서스 균주와 비교하여 우수한 항산화 활성을 가짐을 보여주는 바, 상기 조성물을 항산화 활성 증진을 목적으로 활용할 수 있음을 시사한다.The above results show that the green tea fermented extract of the present invention has excellent antioxidant activity compared to the green tea extract or the known Lactobacillus rhamnosus strain, suggesting that the composition can be used for the purpose of enhancing antioxidant activity. .
실험예 2. 녹차 발효 추출물의 미백 효과 확인Experimental Example 2. Confirmation of whitening effect of fermented green tea extract
락토바실러스 람노서스를 이용한 녹차 발효 추출물의 미백 효과를 확인하기 위하여 티로시네이즈 억제 활성(Tyrosinase inhibition assay)을 확인하기 위한 실험을 수행하였다. 구체적으로, 0.1 M 포타슘 포스페이트 버퍼 (pH 6.8), 2 mM L-티로신(L-tyrosine), 2500 유닛(unit)의 티로시네이즈 및 각 시료들을 농도별로 준비하였다. 96 웰(well) 플레이트에 버퍼 105 μL, L-티로신 70 μL, 티로시네이즈 5 μL, 및 시료용액 20 μL를 넣고 37℃에서 10분간 반응시킨 후, ELISA 리더기(reader)를 이용하여 492 nm에서 흡광도를 측정하였다. 티로시네이즈 저해율의 식은 아래 나타내었다. 이를 바탕으로 티로시네이즈의 활성을 50% 저해시키는데 필요한 시료의 농도(IC50)를 계산하였다. 이때 양성 대조군(positive control)으로는 알부틴(arbutin)을 사용하였다.In order to confirm the whitening effect of the green tea fermented extract using Lactobacillus rhamnosus, an experiment was performed to confirm the tyrosinase inhibition assay. Specifically, 0.1 M potassium phosphate buffer (pH 6.8), 2 mM L-tyrosine, 2500 units of tyrosinase, and each sample were prepared by concentration. In a 96 well plate, 105 μL of buffer, 70 μL of L-tyrosine, 5 μL of tyrosinase, and 20 μL of sample solution were added and reacted at 37°C for 10 minutes, and then at 492 nm using an ELISA reader. The absorbance was measured. The formula of the tyrosinase inhibition rate is shown below. Based on this, the concentration (IC 50 ) of the sample required to inhibit the activity of tyrosinase by 50% was calculated. At this time, arbutin was used as a positive control.
[식 1][Equation 1]
티로시네이즈 억제 활성 (%) = [1 - (B - C)/A] × 100Tyrosinase inhibitory activity (%) = [1-(B-C)/A] × 100
A: 시료를 첨가하지 않은 반응용액의 흡광도A: absorbance of the reaction solution without adding the sample
B: 시료 반응용액의 흡광도B: absorbance of the sample reaction solution
C: 시료만의 흡광도C: absorbance of sample only
그 결과, 도 3에 나타난 바와 같이 락토바실러스 람노서스 AMI-1301의 균주로 발효시킨 녹차 발효 추출물의 티로시네이즈 활성 억제 효과가 녹차 추출물 또는 기존 공지된 락토바실러스 람노서스 균주에 비해 현저히 향상됨을 확인하였는 바, 이는 본 발명의 녹차 발효 추출물이 피부 미백에 우수한 효과가 있음을 시사한다.As a result, it was confirmed that the tyrosinase activity inhibitory effect of the green tea fermented extract fermented with the strain of Lactobacillus rhamnosus AMI-1301 was significantly improved compared to the green tea extract or the known Lactobacillus rhamnosus strain, as shown in FIG. Bar, this suggests that the green tea fermented extract of the present invention has an excellent effect on skin whitening.
실험예 3: 녹차 발효 추출물의 보습 효과 확인Experimental Example 3: Confirmation of moisturizing effect of fermented green tea extract
3-1. MTT 세포 생존력 분석 결과 확인3-1. Confirmation of MTT cell viability assay results
MTT 세포 생존력 분석(MTT Cell Viability Assay)는 인간 표피 상피 세포주 HaCaT을 사용하여 분석을 진행하였다. The MTT Cell Viability Assay was performed using the human epidermal epithelial cell line HaCaT.
상기 세포를 10% 우태아 혈청 (Gibco) 및 1% 페니실린 및 스트렙토마이신 (Gibco)를 함유하는 DMEM (Dulbecco's modified Eagle's media) 배지에서 37℃, 5% CO2하에 배양하였다. 상기 세포는 3~4일에 한번씩 계대배양하였다. 시료 처리는 HaCaT 세포를 24 웰에 각 웰당 1.0 x 105cells/mL로 분주한 후 24 시간 배양하고, 각 웰을 PBS로 2회 세척한 뒤 혈청이 없는(Free serum) 배지를 각 웰당 1 ml를 넣어 교환한 후 각 웰에 시료를 50~100 μg/mL 농도로 처리하였다. 24시간 배양 후 MTT{3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide} 시약을 각 웰 당 500 μg/mL 농도로 배양액에 처리하고, 37℃에서 3시간 반응시킨 후 배양액을 제거하였다. 이후 세포 내 미토콘드리아의 산화환원효소에 의해 환원된 Formazan(보라색)을 DMSO로 녹여 570 nm에서 흡광도를 측정하여 세포생존율을 측정하였다.The cells were cultured in DMEM (Dulbecco's modified Eagle's media) medium containing 10% fetal bovine serum (Gibco) and 1% penicillin and streptomycin (Gibco) at 37° C. and 5% CO 2 . The cells were subcultured once every 3-4 days. For sample treatment, HaCaT cells were dispensed into 24 wells at 1.0 x 10 5 cells/mL per well, cultured for 24 hours, and each well was washed twice with PBS, and then 1 ml of free serum medium was added to each well. After inserting and replacing, the sample was treated at a concentration of 50-100 μg/mL in each well. After incubation for 24 hours, MTT{3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide} reagent was treated in the culture solution at a concentration of 500 μg/mL per well, and reacted at 37°C for 3 hours. After the culture was removed. Thereafter, Formazan (purple), reduced by the oxidoreductase of the mitochondria in cells, was dissolved in DMSO, and the absorbance was measured at 570 nm to measure the cell viability.
그 결과, 표 2에 나타난 바와 같이 각 시료의 모든 농도에서 세포 독성은 확인되지 않았으며, 상기 결과는 상기 시료가 인체에 무해할 뿐만 아니라 인체 안정성이 우수함을 시사한다.As a result, as shown in Table 2, cytotoxicity was not confirmed at all concentrations of each sample, and the results suggest that the sample is not only harmless to the human body, but also has excellent human stability.
3-2. 보습인자 히알루론산(Hyaluronic Acid) 생성량 증가 효과 확인3-2. Confirmation of the effect of increasing the amount of moisturizing factor hyaluronic acid produced
히알루론산 함량 분석(Hyaluronic acid contents Assay)는 인간 표피 상피 세포주 HaCaT을 사용하였다. 상기 세포를 10% 우태아 혈청 (Gibco)와 1% 항생제 (페니실린 및 스트렙토마이신 50,000 units/mL, Gibco)를 함유하는 DMEM 배지 (Dulbecco's modified Eagle's media)에서 37℃, 5% CO2 하에 배양하였다. 세포는 3~4일에 한번씩 계대배양하였다. 샘플 처리는 HaCaT 세포를 24 웰에 각 웰당 1.0 x 105cells/mL로 분주한 후 24시간 배양하고, 각 웰을 PBS로 2회 세척 및 혈청이 없는(Free serum) 배지를 각 웰당 1 ml를 넣어 교환한 후 각 시료를 각 웰에 50~ 100 μg/mL 농도로 처리하였다. 24시간 배양한 세포배양액을 수거하여 히알루론산 ELISA 키트(R&D Systems)를 이용해 히알루론산 농도를 측정하였다.Hyaluronic acid contents Assay used the human epidermal epithelial cell line HaCaT. The cells were cultured in DMEM medium (Dulbecco's modified Eagle's media) containing 10% fetal bovine serum (Gibco) and 1% antibiotics (penicillin and streptomycin 50,000 units/mL, Gibco) at 37° C. and 5% CO 2 . Cells were subcultured once every 3-4 days. For sample treatment, HaCaT cells were aliquoted into 24 wells at 1.0 x 10 5 cells/mL per well and cultured for 24 hours, and each well was washed twice with PBS and 1 ml of free serum medium was added to each well. After putting and exchange, each sample was treated at a concentration of 50 to 100 μg/mL in each well. The cell culture solution cultured for 24 hours was collected, and the hyaluronic acid concentration was measured using a hyaluronic acid ELISA kit (R&D Systems).
그 결과, 표 3에 나타난 바와 같이 락토바실러스 람노서스를 이용한 녹차 발효 추출물이 녹차 추출물에 비해 보습 효과가 향상됨을 확인하였으며, 특히 락토바실러스 람노서스 AMI-1301로 발효시킨 녹차 발효 추출물의 히알루론산 생성량의 증가량이 현저함을 확인하였다.As a result, as shown in Table 3, it was confirmed that the green tea fermented extract using Lactobacillus rhamnosus has improved moisturizing effect compared to the green tea extract. It was confirmed that the amount of increase was remarkable.
실험예 4: 녹차 발효 추출물의 피부 마이크로바이옴 균형 유지 효과 확인Experimental Example 4: Confirmation of the effect of green tea fermentation extract maintaining skin microbiome balance
4-1. 피부 유익균 증식 효과 확인4-1. Confirmation of skin beneficial bacteria proliferation effect
유익균으로서 스트렙토코커스 써모필러스(Streptococcus thermophilus) 균주의 증식 촉진 효과가 있는지 여부를 확인하였다. As a beneficial bacterium, it was confirmed whether there is an effect of promoting the proliferation of Streptococcus thermophilus strain.
먼저, 스트렙토코커스 써모필러스는 케피어 그레인(Kefir grain)으로부터 선별배지를 활용하여 분리하였다. 0.002% BPB-MRS 배지를 사용하여 30℃에서 72시간 동안 혐기 배양을 하였다. 이후, 유산균 콜로니를 선택한 뒤 16S rRNA 시퀀싱을 실시하여 동정하였다.First, Streptococcus thermophilus was isolated from Kefir grain using a sorting medium. Using 0.002% BPB-MRS medium, anaerobic culture was performed at 30° C. for 72 hours. Thereafter, the lactic acid bacteria colonies were selected and identified by performing 16S rRNA sequencing.
이틀 전 미리 깨워 둔 균의 탁도를 2.0으로 맞춘 후 MRS 브로스 3 mL 가 담긴 튜브에 주입한 후, 101 CFU/mL로 희석시키고 초기 균 수를 측정하였다. 이후 3 mL MRS 브로스에 실시예 1의 조성물을을 5 mg 넣고 5분간 초음파 처리(50초 작동, 10초 간격, 5회 반복) 후, DMSO 0.1 % 주입하였다. 동일한 방법으로 3 mL MRS 브로스에 비교예 1 및 2 조성물을 첨가하였으며, 배양시킨 후 균수(CFU/mL)를 측정하였다. Two days ago, the turbidity of the bacteria that had been awakened beforehand was adjusted to 2.0, and then injected into a tube containing 3 mL of MRS broth, diluted with 10 1 CFU/mL, and the initial number of bacteria was measured. Thereafter, 5 mg of the composition of Example 1 was added to 3 mL MRS broth, and sonicated for 5 minutes (operation of 50 seconds, intervals of 10 seconds, repeated 5 times), and 0.1% of DMSO was injected. In the same manner, the compositions of Comparative Examples 1 and 2 were added to 3 mL MRS broth, and the number of bacteria (CFU/mL) was measured after incubation.
그 결과, 상기 표 4에 나타난 바와 같이 스트렙토코커스 써모필러스 균주를 실시예 1에서 배양한 경우 비교예 1 및 2에서 배양한 것과 비교하여 생육이 현저히 증가함을 확인하였다.As a result, as shown in Table 4, when the Streptococcus thermophilus strain was cultured in Example 1, it was confirmed that the growth was significantly increased compared to that cultured in Comparative Examples 1 and 2.
4-2. 피부 유해균 증식 억제 효과 확인4-2. Checking the effect of inhibiting the growth of harmful bacteria on the skin
25세에서 45세 사이의 여성 피험자(평균 연령 33. 8세) 10명을 대상으로 하기 표 5에 따라 제조한 에센스 제형의 화장료 조성물을 1일 2회 안면 피부에 도포한 후 2주 및 4주 후 안면 피부에서 유해균의 변화를 확인하였다. 2 weeks and 4 weeks after applying the cosmetic composition of the essence formulation prepared according to Table 5 below to the facial skin twice a day for 10 female subjects (average age 33. 8 years) between 25 and 45 years old The change of harmful bacteria was confirmed in the facial skin.
먼저 온도와 습도가 일정한 상태(온도 23±2℃, 습도 50±5%) 안면의 양쪽 볼 부분 피부 표면 미생물을 스왑하였다. 스왑은 Quick Swab(3M 마이크로바이올로지, 미국)을 이용하였다. 이후 스왑한 헤드 부분을 멸균된 가위로 잘라 50 mL 코니칼 튜브에 넣고 FastDNA SPIN Kit(고마바이오텍, 한국)의 2X 비즈, 인산 나트륨(sodium phosphate), MT 버퍼를 넣고 20분간 볼텍싱한 후 미생물의 유전체를 추출한 후 Bac9F/Bac541R 프라이머를 이용하여 PCR을 수행하였다(Meisel et al., 2016; Kong, 2016 참조). PCR 산물을 정제한 후 정제된 DNA 샘플을 Quant-iTTM PicoGreen® dsRNA 에세이 키트(인비트로젠, 미국)을 이용하여 정량하여 각각의 샘플이 동량의 DNA를 포함하도록 준비하였다. 이후 파이로시퀀싱(pyrosequencing)을 454 GS FLX 티타늄 시퀀싱 시스템(로쉐, 독일)을 이용하여 수행하였다. 상기 파이로 시퀀싱은 GS FLX 티타늄 시약을 이용하여 제조사의 지시에 따라 사용하였다.First, microbes on the skin surface of both cheeks of the face were swapped in a state where the temperature and humidity were constant (temperature 23±2℃,
16S rDNA유전자로부터 OTUs를 기반으로 한 PICRUSt(phylogenetic investigation of communities by reconstruction of unobserved states)의 생물 정보학 소프트웨어를 이용하여 미생물군집의 메타 유전자분석을 시행하였다. 유해균은 프로피오니박테리움 아크네스(Propionibacterium acnes), 대장균(Escherichia coli) 및 황색포도상구균(Staphylococcus aureus)을 대상으로 하였다.Meta-gene analysis of microbial communities was performed from the 16S rDNA gene using bioinformatics software of PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states) based on OTUs. The harmful bacteria were propionibacterium acnes , Escherichia coli , and Staphylococcus aureus .
그 결과, 상기 에센스를 피부에 일정기간 도포할 경우, 피부 유해균으로 알려진 프로피오니박테리움 아크네스, 대장균 및 황색포도상구균이 모두 감소됨을 확인하였다.As a result, it was confirmed that when the essence was applied to the skin for a certain period of time, all of Propionibacterium acnes, E. coli, and Staphylococcus aureus, known as harmful bacteria for skin, were reduced.
상기 결과는 본 발명의 화장료 조성물이 피부 내 유익균 및 유해균의 생육을 조절하여 피부 마이크로바이옴 균형 유지에 효과적인 조성물임을 시사한다.The above results suggest that the cosmetic composition of the present invention is an effective composition for maintaining the balance of the skin microbiome by controlling the growth of beneficial and harmful bacteria in the skin.
제조예 1. 본 발명의 락토바실러스 람노서스를 이용한 녹차 발효 추출물을 함유하는 에센스 제조Preparation Example 1. Preparation of essence containing green tea fermented extract using Lactobacillus rhamnosus of the present invention
하기의 표 7과 같이 에센스 제형의 화장료 조성물을 제조하였다(단위: 중량%).A cosmetic composition of an essence formulation was prepared as shown in Table 7 below (unit: wt%).
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술 분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시 예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.The above description of the present invention is for illustrative purposes only, and those of ordinary skill in the technical field to which the present invention pertains will be able to understand that it is possible to easily transform it into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, it should be understood that the embodiments described above are illustrative and non-limiting in all respects. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as being distributed may also be implemented in a combined form.
본 발명의 범위는 후술하는 청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the claims to be described later, and all changes or modified forms derived from the meaning and scope of the claims and the concept of equivalents thereof should be construed as being included in the scope of the present invention.
Claims (9)
상기 마이크로바이옴 균형 유지는 피부 유익균을 증진시키거나 또는 피부 유해균을 억제시키는 것인, 화장료 조성물.The method of claim 1,
Maintaining the balance of the microbiome is to promote skin beneficial bacteria or inhibit harmful skin bacteria.
상기 추출물의 용매는 물, 알코올, 에틸아세테이트, 아세톤, 핵산, 디클로로메탄 또는 이들의 혼합 용매인, 화장료 조성물.The method of claim 1,
The solvent of the extract is water, alcohol, ethyl acetate, acetone, nucleic acid, dichloromethane, or a mixed solvent thereof, a cosmetic composition.
상기 조성물은 피부 미백 또는 보습 용도를 추가로 더 포함하는 화장료 조성물. The method of claim 1,
The composition is a cosmetic composition further comprising a skin whitening or moisturizing use.
상기 조성물은 피부 미백 또는 보습 용도를 추가로 더 포함하는 식품 조성물.The method of claim 6,
The composition is a food composition further comprising a skin whitening or moisturizing use.
상기 식품 조성물은 반려 동물용인 것인, 식품 조성물.
The method of claim 6,
The food composition is for companion animals, food composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200077079A KR102194314B1 (en) | 2020-06-24 | 2020-06-24 | Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200077079A KR102194314B1 (en) | 2020-06-24 | 2020-06-24 | Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102194314B1 true KR102194314B1 (en) | 2020-12-23 |
Family
ID=74089002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200077079A KR102194314B1 (en) | 2020-06-24 | 2020-06-24 | Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102194314B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006271219A (en) * | 2005-03-28 | 2006-10-12 | Yonezawa Biru System Service:Kk | Cultured microorganism obtained from medium consisting mainly of green tea and black tea and product using the same |
KR20110117876A (en) * | 2010-04-22 | 2011-10-28 | 웅진코웨이주식회사 | Cosmetic composition comprising flower and tea fermentation extract having anti-oxidant and anti inflammatory effect |
KR20150020521A (en) * | 2013-07-23 | 2015-02-26 | 서원대학교산학협력단 | Method of fermentation using complex strains and cosmetic composition comprising thereof |
KR102074383B1 (en) | 2019-04-26 | 2020-02-06 | 주식회사 락토메이슨 | Skin-whitening cosmetic composition comprising lactobacillus rhamnosus lm1011 having immunostimulating activity |
KR102119825B1 (en) * | 2019-10-15 | 2020-06-05 | 주식회사 아미코스메틱 | A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof |
-
2020
- 2020-06-24 KR KR1020200077079A patent/KR102194314B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006271219A (en) * | 2005-03-28 | 2006-10-12 | Yonezawa Biru System Service:Kk | Cultured microorganism obtained from medium consisting mainly of green tea and black tea and product using the same |
KR20110117876A (en) * | 2010-04-22 | 2011-10-28 | 웅진코웨이주식회사 | Cosmetic composition comprising flower and tea fermentation extract having anti-oxidant and anti inflammatory effect |
KR20150020521A (en) * | 2013-07-23 | 2015-02-26 | 서원대학교산학협력단 | Method of fermentation using complex strains and cosmetic composition comprising thereof |
KR102074383B1 (en) | 2019-04-26 | 2020-02-06 | 주식회사 락토메이슨 | Skin-whitening cosmetic composition comprising lactobacillus rhamnosus lm1011 having immunostimulating activity |
KR102119825B1 (en) * | 2019-10-15 | 2020-06-05 | 주식회사 아미코스메틱 | A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof |
Non-Patent Citations (1)
Title |
---|
Tsai et al, Applications of Lactobacillus rhamnosus Spent Culture Supernatant in Cosmetic Antioxidation, Whitening and Moisture Retention Applications, Molecules, 2013, 18(11), pp.14161-14171 1부.* * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102194315B1 (en) | Antioxidant or skin microbiome balance cosmetic composition comprising centella asiatica fermented extract fermented by inoculating lactobacillus rhamnosus strain | |
KR101492003B1 (en) | Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products | |
KR102119825B1 (en) | A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof | |
KR101634668B1 (en) | Cosmetic composition comprising fermented extract of mistletoe for anti-oxidation or whitening | |
KR20180108209A (en) | Composition for treatment of skin damage comprising tyndallized Lactobacillus rhamnosus JC1225 | |
KR101229045B1 (en) | Extracting method of nelumbo nucifera flower, leaf, stem, root, seed and cosmetic composition for anti-wrinkle containing extracts thereby | |
EP2200574B1 (en) | Novel use of panduratin derivatives or extract of kaempferia pandurata comprising the same | |
KR101360760B1 (en) | Fermented ear shell extract and its cosmetic usage | |
KR101409760B1 (en) | Comprising lactic acid fermentation product of Cirsium japonicum and Gelidium amansil extract as an Active Ingredient for Improving Skin Wrinkle | |
KR20220004328A (en) | Composition for maintaining the balance of microbiome in the skin comprising hampseed oil | |
KR20210155989A (en) | Composition Comprising Lactobacillus sakei, Culture Fluid, or Culture Fluid Extract thereof with Anti-Wrinkling and Elasticity, Skin Cell Regeneration, and Skin Barrier Property as Active Ingredient | |
KR20190048564A (en) | Cosmetic composition comprising concentrate of Omegiju fermented using magma seawater for improving wrinkles, elasticity or moisturizing the skin | |
KR102298533B1 (en) | Antianging cosmetic composition comprising green tea fermented extract fermented by inoculating lactococcus lactis strain | |
KR102298534B1 (en) | Cosmetic composition for skin moisturizing comprising fermented green barley fermented extract fermented by inoculating weisella siberia strain | |
KR102194314B1 (en) | Antioxidant or skin microbiome balance cosmetic composition comprising green tea fermented extract fermented by inoculating lactobacillus rhamnosus strain | |
KR102189326B1 (en) | Composition comprising lava seawater mineral water for promoting beneficial bacteria and suppressing harmful bacteria and method for manufacturing the same | |
KR102370528B1 (en) | Compositions containing Beta vulgaris fermentation extract | |
KR102076656B1 (en) | A cosmetic composition for improving skin aging comprising an extract of femented barley using lactobacillus sp. complex strain as an active ingredient | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR102139000B1 (en) | Antioxidant, anti-wrinkle, whitening and antibiotic cosmetic composition comprising fermented Methyl Sulfonyl methane extract and the preparation method of the same | |
KR102155716B1 (en) | A carrot fermentation method using lactobacillus plantarum ami-1103 strain | |
KR20180041351A (en) | Cosmetic Composition for Whitening of the Skin Comprising the Extract of Fermented Tillandsia usneoides | |
KR20210155987A (en) | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient | |
KR102196276B1 (en) | Probiotic composition comprising green tea fermented extract having antibacterial activity against acne-causing resident skin flora and antioxidant efficacy | |
KR102252855B1 (en) | Cosmetic composition comprising nano-ized lactobacillus genus dead cells and a method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |